These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 8097952
1. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Renesto P, Balloy V, Kamimura T, Masuda K, Imaizumi A, Chignard M. Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952 [Abstract] [Full Text] [Related]
2. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Renesto P, Chignard M. Blood; 1993 Jul 01; 82(1):139-44. PubMed ID: 8324217 [Abstract] [Full Text] [Related]
3. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation. Renesto P, Ferrer-Lopez P, Chignard M. Lab Invest; 1990 Apr 01; 62(4):409-16. PubMed ID: 2159081 [Abstract] [Full Text] [Related]
4. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M. Am J Physiol; 1990 Jun 01; 258(6 Pt 1):C1100-7. PubMed ID: 2360620 [Abstract] [Full Text] [Related]
5. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor. Renesto P, Chignard M. J Lab Clin Med; 1994 Jun 01; 123(6):906-13. PubMed ID: 8201270 [Abstract] [Full Text] [Related]
6. Inhibition by human leukocyte elastase of neutrophil-mediated platelet activation. Renesto P, Balloy V, Chignard M. Eur J Pharmacol; 1993 Aug 02; 248(2):151-5. PubMed ID: 8223961 [Abstract] [Full Text] [Related]
7. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Wright CD, Kennedy JA, Zitnik RJ, Kashem MA. Biochem Biophys Res Commun; 1999 Jan 27; 254(3):614-7. PubMed ID: 9920787 [Abstract] [Full Text] [Related]
9. Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro. Masuda K, Kamimura T, Watanabe K, Suga T, Kanesaki M, Takeuchi A, Imaizumi A, Suzuki Y. Br J Pharmacol; 1995 Jul 27; 115(6):883-8. PubMed ID: 7582515 [Abstract] [Full Text] [Related]
11. Plasma antiproteinase screen and neutrophil-mediated platelet activation. A major role played by alpha 1 antitrypsin. Chignard M, Hazouard E, Renesto P, Laine A, Guidet B, Offenstadt G. Biochim Biophys Acta; 1994 Dec 30; 1224(3):433-40. PubMed ID: 7803500 [Abstract] [Full Text] [Related]
13. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C. Blood; 1991 Jun 01; 77(11):2379-88. PubMed ID: 1645603 [Abstract] [Full Text] [Related]
14. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G. Bangalore N, Travis J. Biol Chem Hoppe Seyler; 1994 Oct 01; 375(10):659-66. PubMed ID: 7888078 [Abstract] [Full Text] [Related]
15. Heparin inhibits neutrophil-induced platelet activation via cathepsin G. Ferrer-Lopez P, Renesto P, Prevost MC, Gounon P, Chignard M. J Lab Clin Med; 1992 Mar 01; 119(3):231-9. PubMed ID: 1541873 [Abstract] [Full Text] [Related]
19. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Bergenfeldt M, Axelsson L, Ohlsson K. Scand J Clin Lab Invest; 1992 Dec 01; 52(8):823-9. PubMed ID: 1362620 [Abstract] [Full Text] [Related]
20. Proteinase 3. A neutrophil proteinase with activity on platelets. Renesto P, Halbwachs-Mecarelli L, Nusbaum P, Lesavre P, Chignard M. J Immunol; 1994 May 01; 152(9):4612-7. PubMed ID: 8157974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]